Exelixis
EXEL
$23.61
Share price
-0.42%
Change (1 day)
25.59%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Operating Margin for Exelixis (EXEL)
Operating Margin as of April 2024 (TTM): 11.86%
According to Exelixis's latest financial reports and stock price the company's current Operating Margin is 11.86%. At the end of 2022 the company had an Operating Margin of 14.55%.
Operating Margin history for Exelixis from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 14.55% | -29.04% |
| 2021 | 20.50% | 54.72% |
| 2020 | 13.25% | -67.79% |
| 2019 | 41.14% | -22.31% |
| 2018 | 52.95% | 51.08% |
| 2017 | 35.05% | -195.55% |
| 2016 | -36.68% | -91.96% |
| 2015 | -456.48% | -57.34% |
| 2014 | -1,070.14% | 36.96% |
| 2013 | -781.34% | 151.29% |
| 2012 | -310.93% | -1269.7% |
| 2011 | 26.58% | -153.23% |
| 2010 | -49.93% | -46.19% |
| 2009 | -92.81% | -39.57% |
| 2008 | -153.57% | -10.17% |
| 2007 | -170.96% | 33.08% |
| 2006 | -128.46% | 2.92% |
| 2005 | -124.81% | -51.93% |
| 2004 | -259.65% | 40.69% |
| 2003 | -184.55% | -3.24% |
| 2002 | -190.73% | 13.94% |
| 2001 | -167.39% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 92.92% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | 191.82% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 191.65% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | 53.54% | 🇫🇷 France |
 Merck MRK | 27.73% | 133.81% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | 62.23% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | 90.05% | 🇬🇧 UK |
 Curis CRIS | -426.66% | -3,697.47% | 🇺🇸 USA |
 AVEO Oncology
AVEO | -30.78% | -359.53% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.